Ha habido 50 transacciones internas recientes registradas para Cidara Therapeutics, Inc. (CDTX), incluyendo 42 compras y 5 ventas. El total de compras internas fue valorado en $30.15M y el total de ventas internas en $96.81K.
Internos destacados con actividad reciente incluyen Burgess Daniel D, Ra Capital Management, L.p., Schroeder Theodore R. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — CDTX
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2025-06-18 |
Burgess Daniel D |
Director |
Concesión de RSU |
11,100 |
$21.31 |
$236.54K |
11,100 |
| 2025-06-18 |
Ra Capital Management, L.p. |
Director |
Concesión de RSU |
5,079 |
$21.31 |
$108.23K |
5,079 |
| 2025-06-18 |
Schroeder Theodore R |
Director |
Concesión de RSU |
11,100 |
$21.31 |
$236.54K |
11,100 |
| 2025-06-18 |
Mineo Chrysa |
Director |
Concesión de RSU |
11,100 |
$21.31 |
$236.54K |
11,100 |
| 2025-06-18 |
Bassler Bonnie L |
Director |
Concesión de RSU |
11,100 |
$21.31 |
$236.54K |
11,100 |
| 2025-06-18 |
Resnick Joshua |
Director |
Concesión de RSU |
5,079 |
$21.31 |
$108.23K |
5,079 |
| 2025-06-18 |
Spencer Ryan |
Director |
Concesión de RSU |
11,100 |
$21.31 |
$236.54K |
11,100 |
| 2025-06-18 |
Canale-theakston Carin |
Director |
Concesión de RSU |
11,100 |
$21.31 |
$236.54K |
11,100 |
| 2025-06-18 |
Merson James |
Director |
Concesión de RSU |
11,100 |
$21.31 |
$236.54K |
11,100 |
| 2025-06-03 |
Mineo Chrysa |
Director |
Compra Informativa |
1,050 |
$23.44 |
$24.61K |
3,320 |
| 2025-06-02 |
Mineo Chrysa |
Director |
Compra Informativa |
2,270 |
$21.71 |
$49.28K |
2,270 |
| 2025-05-01 |
Davarpanah Nicole Negar |
Chief Medical Officer |
Desconocido |
30,000 |
$21.54 |
$646.2K |
- |
| 2025-05-01 |
Davarpanah Nicole Negar |
Chief Medical Officer |
Concesión de RSU |
20,000 |
$21.75 |
$435K |
20,000 |
| 2025-03-31 |
Stein Jeffrey |
President & CEO |
Concesión de RSU |
275,000 |
$21.54 |
$5.92M |
275,000 |
| 2025-03-31 |
Ward Shane |
COO & CLO |
Concesión de RSU |
25,000 |
- |
- |
39,674 |
| 2025-03-11 |
Ward Shane |
COO & CLO |
Venta Informativa |
1,664 |
$21.96 |
$36.54K |
14,674 |
| 2025-03-11 |
Tari Leslie |
Chief Scientific Officer |
Venta Informativa |
1,773 |
$21.96 |
$38.94K |
16,215 |
| 2025-02-24 |
Karbe Frank |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-02-24 |
Karbe Frank |
Chief Financial Officer |
Concesión de RSU |
57,500 |
- |
- |
57,500 |
| 2025-01-03 |
Ra Capital Management, L.p. |
Director |
Concesión de RSU |
22,200 |
$26.62 |
$590.96K |
22,200 |
| 2025-01-03 |
Resnick Joshua |
Director |
Desconocido |
- |
- |
- |
- |
| 2025-01-03 |
Resnick Joshua |
Director |
Concesión de RSU |
22,200 |
$26.62 |
$590.96K |
22,200 |
| 2024-12-17 |
Burgess Daniel D |
Director |
Concesión de RSU |
20,500 |
$22.81 |
$467.61K |
20,500 |
| 2024-12-17 |
Schroeder Theodore R |
Director |
Concesión de RSU |
20,500 |
$22.81 |
$467.61K |
20,500 |
| 2024-12-17 |
Mineo Chrysa |
Director |
Concesión de RSU |
19,000 |
$22.81 |
$433.39K |
19,000 |
| 2024-12-17 |
Bassler Bonnie L |
Director |
Concesión de RSU |
16,000 |
$22.81 |
$364.96K |
16,000 |
| 2024-12-17 |
Canale-theakston Carin |
Director |
Concesión de RSU |
16,000 |
$22.81 |
$364.96K |
16,000 |
| 2024-11-26 |
Ra Capital Management, L.p. |
Director |
Concesión de RSU |
389,716 |
$14.91 |
$5.81M |
1,092,796 |
| 2024-09-30 |
Stein Jeffrey |
President & CEO |
Concesión de RSU |
560,888 |
$10.75 |
$6.03M |
560,888 |
| 2024-09-30 |
Ward Shane |
COO & CLO |
Concesión de RSU |
135,540 |
$10.75 |
$1.46M |
135,540 |
| 2024-09-30 |
Sandison Taylor |
Chief Medical Officer |
Concesión de RSU |
166,836 |
$10.75 |
$1.79M |
166,836 |
| 2024-09-30 |
Shah Preetam |
Chief Financial Officer |
Concesión de RSU |
130,087 |
$10.75 |
$1.4M |
130,087 |
| 2024-09-30 |
Tari Leslie |
Chief Scientific Officer |
Concesión de RSU |
150,224 |
$10.75 |
$1.61M |
150,224 |
| 2024-09-11 |
Sandison Taylor |
Chief Medical Officer |
Venta Informativa |
924 |
$11.64 |
$10.75K |
23,067 |
| 2024-09-11 |
Tari Leslie |
Chief Scientific Officer |
Venta Informativa |
909 |
$11.64 |
$10.58K |
17,788 |
| 2024-07-19 |
Ra Capital Management, L.p. |
Director |
Conversión (Venta) |
10,044 |
- |
- |
89,956 |
| 2024-07-18 |
Burgess Daniel D |
Director |
Concesión de RSU |
2,125 |
$12.64 |
$26.86K |
2,125 |
| 2024-07-18 |
Ra Capital Management, L.p. |
Director |
Concesión de RSU |
2,125 |
$1.00 |
$2.13K |
2,125 |
| 2024-07-18 |
Schroeder Theodore R |
Director |
Concesión de RSU |
2,125 |
$12.64 |
$26.86K |
2,125 |
| 2024-07-18 |
Mineo Chrysa |
Director |
Concesión de RSU |
2,125 |
$12.64 |
$26.86K |
2,125 |
| 2024-07-18 |
Bassler Bonnie L |
Director |
Concesión de RSU |
2,125 |
$12.64 |
$26.86K |
2,125 |
| 2024-07-18 |
Spencer Ryan |
Director |
Concesión de RSU |
2,125 |
$12.64 |
$26.86K |
2,125 |
| 2024-07-18 |
Canale-theakston Carin |
Director |
Concesión de RSU |
2,125 |
$12.64 |
$26.86K |
2,125 |
| 2024-07-18 |
Tadvalkar Laura |
Director |
Concesión de RSU |
2,125 |
$12.64 |
$26.86K |
2,125 |
| 2024-07-18 |
Merson James |
Director |
Concesión de RSU |
2,125 |
$12.64 |
$26.86K |
2,125 |
| 2024-07-18 |
Ra Capital Management, L.p. |
Director |
Concesión de RSU |
100,000 |
- |
- |
100,000 |
| 2024-07-18 |
Ra Capital Management, L.p. |
Director |
Concesión de RSU |
2,125 |
$12.64 |
$26.86K |
2,125 |
| 2024-06-07 |
Stein Jeffrey |
President & CEO |
Compra Informativa |
8,000 |
$13.21 |
$105.68K |
24,580 |
| 2024-04-26 |
Ra Capital Management, L.p. |
Director |
Concesión de RSU |
4,250 |
$12.63 |
$53.68K |
4,250 |
| 2024-04-26 |
Spencer Ryan |
Director |
Concesión de RSU |
4,250 |
$12.63 |
$53.68K |
4,250 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
